Key Takeaways
- RKLB stock declined 10.15% after the company announced Neutron’s first flight will slip to 2027.
- Manufacturing flaws, including air pockets in carbon-composite tank structures, necessitate additional repairs.
- The postponement follows January’s tank rupture incident during ground testing.
- KeyBanc reduced its price target to $100, while Clear Street adjusted its forecast to $105.
- The company’s Electron vehicle operations remain active amid ongoing Neutron development challenges.
Shares of Rocket Lab Corporation (RKLB) dropped 10.15% to close at $53.17 Thursday, shedding $6.01 after the aerospace manufacturer revealed another significant delay for its Neutron rocket program. The company disclosed that manufacturing quality issues in critical carbon-composite components have forced it to extend the medium-lift vehicle’s inaugural launch timeline into 2027. This latest postponement represents a fresh obstacle in Rocket Lab’s strategy to challenge established players in the lucrative mid-size launch sector.
Manufacturing Quality Issues Discovered in Critical Neutron Components
Rocket Lab revealed the updated timeline Wednesday through both an investor communication and Securities and Exchange Commission filing. The aerospace firm detected manufacturing irregularities affecting the carbon composite materials used in Neutron’s first-stage barrel sections and fuel tank dome structures. These elements are crucial for maintaining structural integrity and safely storing cryogenic propellants throughout flight operations.
During quality control procedures, technical teams identified small voids within the propellant tank dome cap’s composite layup. Such imperfections can compromise the mechanical properties of composite materials and pose safety hazards under the extreme pressures and temperatures experienced during rocket operations. The company has implemented enhanced manufacturing protocols to eliminate these defects and improve the reliability of future components.
This setback arrives on the heels of a January incident involving a catastrophic failure of a first-stage propellant tank during pressure testing. Following that event, Rocket Lab had already adjusted its launch projection to late 2026. The discovery of additional manufacturing complications has now necessitated pushing the schedule further into 2027, beyond the company’s most recent public guidance.
Neutron Delay Postpones Revenue Growth From Medium-Lift Market
Neutron represents the centerpiece of Rocket Lab’s strategy to diversify beyond its existing Electron small-satellite launch service and capture demand for heavier payloads. The partially reusable launch system is designed to compete directly with SpaceX’s Falcon 9 for both commercial satellite deployments and national security missions. The extended development period, however, defers Neutron’s market entry and the revenue streams it was expected to generate.
Rocket Lab’s journey with Neutron began in 2021 when the company first unveiled the rocket concept with an initial target of reaching the launch pad in 2024. As design validation and component testing progressed, the company revised its expectations to 2025. Ongoing technical hurdles, manufacturing setbacks, and testing failures have now extended the timeline by an additional two years to 2027.
Despite Neutron’s challenges, Rocket Lab maintains its operational cadence with the Electron small-launch vehicle and advances its HASTE hypersonic flight capabilities. The company secured a significant contract in September covering 20 Electron missions for Synspective, a Japanese Earth-observation satellite operator, providing steady revenue while Neutron undergoes the necessary manufacturing refinements and qualification testing.
Analysts Lower RKLB Stock Valuations Following Timeline Extension
The Neutron delay prompted immediate responses from equity research firms covering the stock. KeyBanc Capital Markets slashed its price target for RKLB from $135 to $100, reflecting concerns about the postponed revenue timeline and continued development expenditures. Clear Street also adjusted its valuation downward from $129 to $105 as analysts recalibrated their models based on the later-than-expected commercial debut.
The revised schedule means Rocket Lab will incur additional development costs throughout the extended testing period before Neutron can transition to revenue-generating commercial operations. The company faces substantial engineering work ahead, including manufacturing process validation, component re-qualification, and comprehensive system-level testing before attempting a maiden flight. These milestones will determine whether the 2027 target proves achievable or requires further adjustment.
Rocket Lab has committed to providing regular updates as Neutron progresses through its remaining development phases. The company has made supplementary technical information available through its investor relations channels. Future disclosures will offer stakeholders visibility into whether manufacturing improvements successfully address the quality issues and keep the program on track for its 2027 launch window.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
